Global Amifostine Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
According to APO Research, The global Amifostine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Amifostine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Amifostine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Amifostine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Amifostine include Clinigen, Sun Pharmaceutical, Taj Pharmaceuticals, Merro Pharmaceutical, Luye Pharma and Mingren Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Amifostine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amifostine.
The Amifostine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amifostine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amifostine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amifostine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amifostine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amifostine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Amifostine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
According to APO Research, The global Amifostine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Amifostine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Amifostine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Amifostine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Amifostine include Clinigen, Sun Pharmaceutical, Taj Pharmaceuticals, Merro Pharmaceutical, Luye Pharma and Mingren Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Amifostine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amifostine.
The Amifostine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amifostine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Clinigen
- Sun Pharmaceutical
- Taj Pharmaceuticals
- Merro Pharmaceutical
- Luye Pharma
- Mingren Pharma
- 400mg/Dose
- 500mg/Dose
- Head and Neck Cancer Adjuvant Therapy
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amifostine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amifostine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amifostine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amifostine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Amifostine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Amifostine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Amifostine Sales Estimates and Forecasts (2019-2030)
1.3 Amifostine Market by Type
1.3.1 400mg/Dose
1.3.2 500mg/Dose
1.4 Global Amifostine Market Size by Type
1.4.1 Global Amifostine Market Size Overview by Type (2019-2030)
1.4.2 Global Amifostine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Amifostine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Amifostine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Amifostine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Amifostine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Amifostine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Amifostine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Amifostine Industry Trends
2.2 Amifostine Industry Drivers
2.3 Amifostine Industry Opportunities and Challenges
2.4 Amifostine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Amifostine Revenue (2019-2024)
3.2 Global Top Players by Amifostine Sales (2019-2024)
3.3 Global Top Players by Amifostine Price (2019-2024)
3.4 Global Amifostine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Amifostine Key Company Manufacturing Sites & Headquarters
3.6 Global Amifostine Company, Product Type & Application
3.7 Global Amifostine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Amifostine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Amifostine Players Market Share by Revenue in 2023
3.8.3 2023 Amifostine Tier 1, Tier 2, and Tier
4 AMIFOSTINE REGIONAL STATUS AND OUTLOOK
4.1 Global Amifostine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Amifostine Historic Market Size by Region
4.2.1 Global Amifostine Sales in Volume by Region (2019-2024)
4.2.2 Global Amifostine Sales in Value by Region (2019-2024)
4.2.3 Global Amifostine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Amifostine Forecasted Market Size by Region
4.3.1 Global Amifostine Sales in Volume by Region (2025-2030)
4.3.2 Global Amifostine Sales in Value by Region (2025-2030)
4.3.3 Global Amifostine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 AMIFOSTINE BY APPLICATION
5.1 Amifostine Market by Application
5.1.1 Head and Neck Cancer Adjuvant Therapy
5.1.2 Others
5.2 Global Amifostine Market Size by Application
5.2.1 Global Amifostine Market Size Overview by Application (2019-2030)
5.2.2 Global Amifostine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Amifostine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Amifostine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Amifostine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Amifostine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Amifostine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Amifostine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Clinigen
6.1.1 Clinigen Comapny Information
6.1.2 Clinigen Business Overview
6.1.3 Clinigen Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Clinigen Amifostine Product Portfolio
6.1.5 Clinigen Recent Developments
6.2 Sun Pharmaceutical
6.2.1 Sun Pharmaceutical Comapny Information
6.2.2 Sun Pharmaceutical Business Overview
6.2.3 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sun Pharmaceutical Amifostine Product Portfolio
6.2.5 Sun Pharmaceutical Recent Developments
6.3 Taj Pharmaceuticals
6.3.1 Taj Pharmaceuticals Comapny Information
6.3.2 Taj Pharmaceuticals Business Overview
6.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Taj Pharmaceuticals Amifostine Product Portfolio
6.3.5 Taj Pharmaceuticals Recent Developments
6.4 Merro Pharmaceutical
6.4.1 Merro Pharmaceutical Comapny Information
6.4.2 Merro Pharmaceutical Business Overview
6.4.3 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merro Pharmaceutical Amifostine Product Portfolio
6.4.5 Merro Pharmaceutical Recent Developments
6.5 Luye Pharma
6.5.1 Luye Pharma Comapny Information
6.5.2 Luye Pharma Business Overview
6.5.3 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Luye Pharma Amifostine Product Portfolio
6.5.5 Luye Pharma Recent Developments
6.6 Mingren Pharma
6.6.1 Mingren Pharma Comapny Information
6.6.2 Mingren Pharma Business Overview
6.6.3 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mingren Pharma Amifostine Product Portfolio
6.6.5 Mingren Pharma Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Amifostine Sales by Country
7.1.1 North America Amifostine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Amifostine Sales by Country (2019-2024)
7.1.3 North America Amifostine Sales Forecast by Country (2025-2030)
7.2 North America Amifostine Market Size by Country
7.2.1 North America Amifostine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Amifostine Market Size by Country (2019-2024)
7.2.3 North America Amifostine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Amifostine Sales by Country
8.1.1 Europe Amifostine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Amifostine Sales by Country (2019-2024)
8.1.3 Europe Amifostine Sales Forecast by Country (2025-2030)
8.2 Europe Amifostine Market Size by Country
8.2.1 Europe Amifostine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Amifostine Market Size by Country (2019-2024)
8.2.3 Europe Amifostine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Amifostine Sales by Country
9.1.1 Asia-Pacific Amifostine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Amifostine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Amifostine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Amifostine Market Size by Country
9.2.1 Asia-Pacific Amifostine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Amifostine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Amifostine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Amifostine Sales by Country
10.1.1 Latin America Amifostine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Amifostine Sales by Country (2019-2024)
10.1.3 Latin America Amifostine Sales Forecast by Country (2025-2030)
10.2 Latin America Amifostine Market Size by Country
10.2.1 Latin America Amifostine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Amifostine Market Size by Country (2019-2024)
10.2.3 Latin America Amifostine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Amifostine Sales by Country
11.1.1 Middle East and Africa Amifostine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Amifostine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Amifostine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Amifostine Market Size by Country
11.2.1 Middle East and Africa Amifostine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Amifostine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Amifostine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Amifostine Value Chain Analysis
12.1.1 Amifostine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Amifostine Production Mode & Process
12.2 Amifostine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Amifostine Distributors
12.2.3 Amifostine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Amifostine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Amifostine Sales Estimates and Forecasts (2019-2030)
1.3 Amifostine Market by Type
1.3.1 400mg/Dose
1.3.2 500mg/Dose
1.4 Global Amifostine Market Size by Type
1.4.1 Global Amifostine Market Size Overview by Type (2019-2030)
1.4.2 Global Amifostine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Amifostine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Amifostine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Amifostine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Amifostine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Amifostine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Amifostine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Amifostine Industry Trends
2.2 Amifostine Industry Drivers
2.3 Amifostine Industry Opportunities and Challenges
2.4 Amifostine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Amifostine Revenue (2019-2024)
3.2 Global Top Players by Amifostine Sales (2019-2024)
3.3 Global Top Players by Amifostine Price (2019-2024)
3.4 Global Amifostine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Amifostine Key Company Manufacturing Sites & Headquarters
3.6 Global Amifostine Company, Product Type & Application
3.7 Global Amifostine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Amifostine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Amifostine Players Market Share by Revenue in 2023
3.8.3 2023 Amifostine Tier 1, Tier 2, and Tier
4 AMIFOSTINE REGIONAL STATUS AND OUTLOOK
4.1 Global Amifostine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Amifostine Historic Market Size by Region
4.2.1 Global Amifostine Sales in Volume by Region (2019-2024)
4.2.2 Global Amifostine Sales in Value by Region (2019-2024)
4.2.3 Global Amifostine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Amifostine Forecasted Market Size by Region
4.3.1 Global Amifostine Sales in Volume by Region (2025-2030)
4.3.2 Global Amifostine Sales in Value by Region (2025-2030)
4.3.3 Global Amifostine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 AMIFOSTINE BY APPLICATION
5.1 Amifostine Market by Application
5.1.1 Head and Neck Cancer Adjuvant Therapy
5.1.2 Others
5.2 Global Amifostine Market Size by Application
5.2.1 Global Amifostine Market Size Overview by Application (2019-2030)
5.2.2 Global Amifostine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Amifostine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Amifostine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Amifostine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Amifostine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Amifostine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Amifostine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Clinigen
6.1.1 Clinigen Comapny Information
6.1.2 Clinigen Business Overview
6.1.3 Clinigen Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Clinigen Amifostine Product Portfolio
6.1.5 Clinigen Recent Developments
6.2 Sun Pharmaceutical
6.2.1 Sun Pharmaceutical Comapny Information
6.2.2 Sun Pharmaceutical Business Overview
6.2.3 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sun Pharmaceutical Amifostine Product Portfolio
6.2.5 Sun Pharmaceutical Recent Developments
6.3 Taj Pharmaceuticals
6.3.1 Taj Pharmaceuticals Comapny Information
6.3.2 Taj Pharmaceuticals Business Overview
6.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Taj Pharmaceuticals Amifostine Product Portfolio
6.3.5 Taj Pharmaceuticals Recent Developments
6.4 Merro Pharmaceutical
6.4.1 Merro Pharmaceutical Comapny Information
6.4.2 Merro Pharmaceutical Business Overview
6.4.3 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merro Pharmaceutical Amifostine Product Portfolio
6.4.5 Merro Pharmaceutical Recent Developments
6.5 Luye Pharma
6.5.1 Luye Pharma Comapny Information
6.5.2 Luye Pharma Business Overview
6.5.3 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Luye Pharma Amifostine Product Portfolio
6.5.5 Luye Pharma Recent Developments
6.6 Mingren Pharma
6.6.1 Mingren Pharma Comapny Information
6.6.2 Mingren Pharma Business Overview
6.6.3 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mingren Pharma Amifostine Product Portfolio
6.6.5 Mingren Pharma Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Amifostine Sales by Country
7.1.1 North America Amifostine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Amifostine Sales by Country (2019-2024)
7.1.3 North America Amifostine Sales Forecast by Country (2025-2030)
7.2 North America Amifostine Market Size by Country
7.2.1 North America Amifostine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Amifostine Market Size by Country (2019-2024)
7.2.3 North America Amifostine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Amifostine Sales by Country
8.1.1 Europe Amifostine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Amifostine Sales by Country (2019-2024)
8.1.3 Europe Amifostine Sales Forecast by Country (2025-2030)
8.2 Europe Amifostine Market Size by Country
8.2.1 Europe Amifostine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Amifostine Market Size by Country (2019-2024)
8.2.3 Europe Amifostine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Amifostine Sales by Country
9.1.1 Asia-Pacific Amifostine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Amifostine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Amifostine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Amifostine Market Size by Country
9.2.1 Asia-Pacific Amifostine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Amifostine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Amifostine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Amifostine Sales by Country
10.1.1 Latin America Amifostine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Amifostine Sales by Country (2019-2024)
10.1.3 Latin America Amifostine Sales Forecast by Country (2025-2030)
10.2 Latin America Amifostine Market Size by Country
10.2.1 Latin America Amifostine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Amifostine Market Size by Country (2019-2024)
10.2.3 Latin America Amifostine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Amifostine Sales by Country
11.1.1 Middle East and Africa Amifostine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Amifostine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Amifostine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Amifostine Market Size by Country
11.2.1 Middle East and Africa Amifostine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Amifostine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Amifostine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Amifostine Value Chain Analysis
12.1.1 Amifostine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Amifostine Production Mode & Process
12.2 Amifostine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Amifostine Distributors
12.2.3 Amifostine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of 400mg/Dose
Table 2. Major Company of 500mg/Dose
Table 3. Global Amifostine Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global Amifostine Sales by Type (2019-2024) & (K Units)
Table 5. Global Amifostine Sales Market Share in Volume by Type (2019-2024)
Table 6. Global Amifostine Sales by Type (2019-2024) & (US$ Million)
Table 7. Global Amifostine Sales Market Share in Value by Type (2019-2024)
Table 8. Global Amifostine Price by Type (2019-2024) & (USD/Unit)
Table 9. Global Amifostine Sales by Type (2025-2030) & (K Units)
Table 10. Global Amifostine Sales Market Share in Volume by Type (2025-2030)
Table 11. Global Amifostine Sales by Type (2025-2030) & (US$ Million)
Table 12. Global Amifostine Sales Market Share in Value by Type (2025-2030)
Table 13. Global Amifostine Price by Type (2025-2030) & (USD/Unit)
Table 14. North America Amifostine Sales by Type (2019-2024) & (K Units)
Table 15. North America Amifostine Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe Amifostine Sales by Type (2019-2024) & (K Units)
Table 17. Europe Amifostine Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific Amifostine Sales by Type (2019-2024) & (K Units)
Table 19. Asia-Pacific Amifostine Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America Amifostine Sales by Type (2019-2024) & (K Units)
Table 21. Latin America Amifostine Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa Amifostine Sales by Type (2019-2024) & (K Units)
Table 23. Middle East and Africa Amifostine Sales by Type (2019-2024) & (US$ Million)
Table 24. Amifostine Industry Trends
Table 25. Amifostine Industry Drivers
Table 26. Amifostine Industry Opportunities and Challenges
Table 27. Amifostine Industry Restraints
Table 28. Global Amifostine Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global Amifostine Revenue Market Share by Company (2019-2024)
Table 30. Global Amifostine Sales by Company (2019-2024) & (K Units)
Table 31. Global Amifostine Sales Share by Company (2019-2024)
Table 32. Global Amifostine Market Price by Company (2019-2024) & (USD/Unit)
Table 33. Global Amifostine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global Amifostine Key Company Manufacturing Sites & Headquarters
Table 35. Global Amifostine Company, Product Type & Application
Table 36. Global Amifostine Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Amifostine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global Amifostine Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global Amifostine Sales by Region (2019-2024) & (K Units)
Table 41. Global Amifostine Sales Market Share in Volume by Region (2019-2024)
Table 42. Global Amifostine Sales by Region (2019-2024) & (US$ Million)
Table 43. Global Amifostine Sales Market Share in Value by Region (2019-2024)
Table 44. Global Amifostine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 45. Global Amifostine Sales by Region (2025-2030) & (K Units)
Table 46. Global Amifostine Sales Market Share in Volume by Region (2025-2030)
Table 47. Global Amifostine Sales by Region (2025-2030) & (US$ Million)
Table 48. Global Amifostine Sales Market Share in Value by Region (2025-2030)
Table 49. Global Amifostine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2025-2030)
Table 50. Global Amifostine Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global Amifostine Sales by Application (2019-2024) & (K Units)
Table 52. Global Amifostine Sales Market Share in Volume by Application (2019-2024)
Table 53. Global Amifostine Sales by Application (2019-2024) & (US$ Million)
Table 54. Global Amifostine Sales Market Share in Value by Application (2019-2024)
Table 55. Global Amifostine Price by Application (2019-2024) & (USD/Unit)
Table 56. Global Amifostine Sales by Application (2025-2030) & (K Units)
Table 57. Global Amifostine Sales Market Share in Volume by Application (2025-2030)
Table 58. Global Amifostine Sales by Application (2025-2030) & (US$ Million)
Table 59. Global Amifostine Sales Market Share in Value by Application (2025-2030)
Table 60. Global Amifostine Price by Application (2025-2030) & (USD/Unit)
Table 61. North America Amifostine Sales by Application (2019-2024) & (K Units)
Table 62. North America Amifostine Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe Amifostine Sales by Application (2019-2024) & (K Units)
Table 64. Europe Amifostine Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific Amifostine Sales by Application (2019-2024) & (K Units)
Table 66. Asia-Pacific Amifostine Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America Amifostine Sales by Application (2019-2024) & (K Units)
Table 68. Latin America Amifostine Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa Amifostine Sales by Application (2019-2024) & (K Units)
Table 70. Middle East and Africa Amifostine Sales by Application (2019-2024) & (US$ Million)
Table 71. Clinigen Company Information
Table 72. Clinigen Business Overview
Table 73. Clinigen Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Clinigen Amifostine Product Portfolio
Table 75. Clinigen Recent Development
Table 76. Sun Pharmaceutical Company Information
Table 77. Sun Pharmaceutical Business Overview
Table 78. Sun Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Sun Pharmaceutical Amifostine Product Portfolio
Table 80. Sun Pharmaceutical Recent Development
Table 81. Taj Pharmaceuticals Company Information
Table 82. Taj Pharmaceuticals Business Overview
Table 83. Taj Pharmaceuticals Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Taj Pharmaceuticals Amifostine Product Portfolio
Table 85. Taj Pharmaceuticals Recent Development
Table 86. Merro Pharmaceutical Company Information
Table 87. Merro Pharmaceutical Business Overview
Table 88. Merro Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Merro Pharmaceutical Amifostine Product Portfolio
Table 90. Merro Pharmaceutical Recent Development
Table 91. Luye Pharma Company Information
Table 92. Luye Pharma Business Overview
Table 93. Luye Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Luye Pharma Amifostine Product Portfolio
Table 95. Luye Pharma Recent Development
Table 96. Mingren Pharma Company Information
Table 97. Mingren Pharma Business Overview
Table 98. Mingren Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Mingren Pharma Amifostine Product Portfolio
Table 100. Mingren Pharma Recent Development
Table 101. North America Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 102. North America Amifostine Sales by Country (2019-2024) & (K Units)
Table 103. North America Amifostine Sales Market Share by Country (2019-2024)
Table 104. North America Amifostine Sales Forecast by Country (2025-2030) & (K Units)
Table 105. North America Amifostine Sales Market Share Forecast by Country (2025-2030)
Table 106. North America Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 107. North America Amifostine Market Size by Country (2019-2024) & (US$ Million)
Table 108. North America Amifostine Market Share by Country (2019-2024)
Table 109. North America Amifostine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 110. North America Amifostine Market Share Forecast by Country (2025-2030)
Table 111. Europe Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 112. Europe Amifostine Sales by Country (2019-2024) & (K Units)
Table 113. Europe Amifostine Sales Market Share by Country (2019-2024)
Table 114. Europe Amifostine Sales Forecast by Country (2025-2030) & (K Units)
Table 115. Europe Amifostine Sales Market Share Forecast by Country (2025-2030)
Table 116. Europe Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 117. Europe Amifostine Market Size by Country (2019-2024) & (US$ Million)
Table 118. Europe Amifostine Market Share by Country (2019-2024)
Table 119. Europe Amifostine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 120. Europe Amifostine Market Share Forecast by Country (2025-2030)
Table 121. Asia-Pacific Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 122. Asia-Pacific Amifostine Sales by Country (2019-2024) & (K Units)
Table 123. Asia-Pacific Amifostine Sales Market Share by Country (2019-2024)
Table 124. Asia-Pacific Amifostine Sales Forecast by Country (2025-2030) & (K Units)
Table 125. Asia-Pacific Amifostine Sales Market Share Forecast by Country (2025-2030)
Table 126. Asia-Pacific Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 127. Asia-Pacific Amifostine Market Size by Country (2019-2024) & (US$ Million)
Table 128. Asia-Pacific Amifostine Market Share by Country (2019-2024)
Table 129. Asia-Pacific Amifostine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 130. Asia-Pacific Amifostine Market Share Forecast by Country (2025-2030)
Table 131. Latin America Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 132. Latin America Amifostine Sales by Country (2019-2024) & (K Units)
Table 133. Latin America Amifostine Sales Market Share by Country (2019-2024)
Table 134. Latin America Amifostine Sales Forecast by Country (2025-2030) & (K Units)
Table 135. Latin America Amifostine Sales Market Share Forecast by Country (2025-2030)
Table 136. Latin America Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 137. Latin America Amifostine Market Size by Country (2019-2024) & (US$ Million)
Table 138. Latin America Amifostine Market Share by Country (2019-2024)
Table 139. Latin America Amifostine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 140. Latin America Amifostine Market Share Forecast by Country (2025-2030)
Table 141. Middle East and Africa Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 142. Middle East and Africa Amifostine Sales by Country (2019-2024) & (K Units)
Table 143. Middle East and Africa Amifostine Sales Market Share by Country (2019-2024)
Table 144. Middle East and Africa Amifostine Sales Forecast by Country (2025-2030) & (K Units)
Table 145. Middle East and Africa Amifostine Sales Market Share Forecast by Country (2025-2030)
Table 146. Middle East and Africa Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 147. Middle East and Africa Amifostine Market Size by Country (2019-2024) & (US$ Million)
Table 148. Middle East and Africa Amifostine Market Share by Country (2019-2024)
Table 149. Middle East and Africa Amifostine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 150. Middle East and Africa Amifostine Market Share Forecast by Country (2025-2030)
Table 151. Key Raw Materials
Table 152. Raw Materials Key Suppliers
Table 153. Amifostine Distributors List
Table 154. Amifostine Customers List
Table 155. Research Programs/Design for This Report
Table 156. Authors List of This Report
Table 157. Secondary Sources
Table 158. Primary Sources
Table 1. Major Company of 400mg/Dose
Table 2. Major Company of 500mg/Dose
Table 3. Global Amifostine Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global Amifostine Sales by Type (2019-2024) & (K Units)
Table 5. Global Amifostine Sales Market Share in Volume by Type (2019-2024)
Table 6. Global Amifostine Sales by Type (2019-2024) & (US$ Million)
Table 7. Global Amifostine Sales Market Share in Value by Type (2019-2024)
Table 8. Global Amifostine Price by Type (2019-2024) & (USD/Unit)
Table 9. Global Amifostine Sales by Type (2025-2030) & (K Units)
Table 10. Global Amifostine Sales Market Share in Volume by Type (2025-2030)
Table 11. Global Amifostine Sales by Type (2025-2030) & (US$ Million)
Table 12. Global Amifostine Sales Market Share in Value by Type (2025-2030)
Table 13. Global Amifostine Price by Type (2025-2030) & (USD/Unit)
Table 14. North America Amifostine Sales by Type (2019-2024) & (K Units)
Table 15. North America Amifostine Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe Amifostine Sales by Type (2019-2024) & (K Units)
Table 17. Europe Amifostine Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific Amifostine Sales by Type (2019-2024) & (K Units)
Table 19. Asia-Pacific Amifostine Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America Amifostine Sales by Type (2019-2024) & (K Units)
Table 21. Latin America Amifostine Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa Amifostine Sales by Type (2019-2024) & (K Units)
Table 23. Middle East and Africa Amifostine Sales by Type (2019-2024) & (US$ Million)
Table 24. Amifostine Industry Trends
Table 25. Amifostine Industry Drivers
Table 26. Amifostine Industry Opportunities and Challenges
Table 27. Amifostine Industry Restraints
Table 28. Global Amifostine Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global Amifostine Revenue Market Share by Company (2019-2024)
Table 30. Global Amifostine Sales by Company (2019-2024) & (K Units)
Table 31. Global Amifostine Sales Share by Company (2019-2024)
Table 32. Global Amifostine Market Price by Company (2019-2024) & (USD/Unit)
Table 33. Global Amifostine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global Amifostine Key Company Manufacturing Sites & Headquarters
Table 35. Global Amifostine Company, Product Type & Application
Table 36. Global Amifostine Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Amifostine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global Amifostine Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global Amifostine Sales by Region (2019-2024) & (K Units)
Table 41. Global Amifostine Sales Market Share in Volume by Region (2019-2024)
Table 42. Global Amifostine Sales by Region (2019-2024) & (US$ Million)
Table 43. Global Amifostine Sales Market Share in Value by Region (2019-2024)
Table 44. Global Amifostine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 45. Global Amifostine Sales by Region (2025-2030) & (K Units)
Table 46. Global Amifostine Sales Market Share in Volume by Region (2025-2030)
Table 47. Global Amifostine Sales by Region (2025-2030) & (US$ Million)
Table 48. Global Amifostine Sales Market Share in Value by Region (2025-2030)
Table 49. Global Amifostine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2025-2030)
Table 50. Global Amifostine Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global Amifostine Sales by Application (2019-2024) & (K Units)
Table 52. Global Amifostine Sales Market Share in Volume by Application (2019-2024)
Table 53. Global Amifostine Sales by Application (2019-2024) & (US$ Million)
Table 54. Global Amifostine Sales Market Share in Value by Application (2019-2024)
Table 55. Global Amifostine Price by Application (2019-2024) & (USD/Unit)
Table 56. Global Amifostine Sales by Application (2025-2030) & (K Units)
Table 57. Global Amifostine Sales Market Share in Volume by Application (2025-2030)
Table 58. Global Amifostine Sales by Application (2025-2030) & (US$ Million)
Table 59. Global Amifostine Sales Market Share in Value by Application (2025-2030)
Table 60. Global Amifostine Price by Application (2025-2030) & (USD/Unit)
Table 61. North America Amifostine Sales by Application (2019-2024) & (K Units)
Table 62. North America Amifostine Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe Amifostine Sales by Application (2019-2024) & (K Units)
Table 64. Europe Amifostine Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific Amifostine Sales by Application (2019-2024) & (K Units)
Table 66. Asia-Pacific Amifostine Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America Amifostine Sales by Application (2019-2024) & (K Units)
Table 68. Latin America Amifostine Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa Amifostine Sales by Application (2019-2024) & (K Units)
Table 70. Middle East and Africa Amifostine Sales by Application (2019-2024) & (US$ Million)
Table 71. Clinigen Company Information
Table 72. Clinigen Business Overview
Table 73. Clinigen Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Clinigen Amifostine Product Portfolio
Table 75. Clinigen Recent Development
Table 76. Sun Pharmaceutical Company Information
Table 77. Sun Pharmaceutical Business Overview
Table 78. Sun Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Sun Pharmaceutical Amifostine Product Portfolio
Table 80. Sun Pharmaceutical Recent Development
Table 81. Taj Pharmaceuticals Company Information
Table 82. Taj Pharmaceuticals Business Overview
Table 83. Taj Pharmaceuticals Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Taj Pharmaceuticals Amifostine Product Portfolio
Table 85. Taj Pharmaceuticals Recent Development
Table 86. Merro Pharmaceutical Company Information
Table 87. Merro Pharmaceutical Business Overview
Table 88. Merro Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Merro Pharmaceutical Amifostine Product Portfolio
Table 90. Merro Pharmaceutical Recent Development
Table 91. Luye Pharma Company Information
Table 92. Luye Pharma Business Overview
Table 93. Luye Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Luye Pharma Amifostine Product Portfolio
Table 95. Luye Pharma Recent Development
Table 96. Mingren Pharma Company Information
Table 97. Mingren Pharma Business Overview
Table 98. Mingren Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Mingren Pharma Amifostine Product Portfolio
Table 100. Mingren Pharma Recent Development
Table 101. North America Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 102. North America Amifostine Sales by Country (2019-2024) & (K Units)
Table 103. North America Amifostine Sales Market Share by Country (2019-2024)
Table 104. North America Amifostine Sales Forecast by Country (2025-2030) & (K Units)
Table 105. North America Amifostine Sales Market Share Forecast by Country (2025-2030)
Table 106. North America Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 107. North America Amifostine Market Size by Country (2019-2024) & (US$ Million)
Table 108. North America Amifostine Market Share by Country (2019-2024)
Table 109. North America Amifostine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 110. North America Amifostine Market Share Forecast by Country (2025-2030)
Table 111. Europe Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 112. Europe Amifostine Sales by Country (2019-2024) & (K Units)
Table 113. Europe Amifostine Sales Market Share by Country (2019-2024)
Table 114. Europe Amifostine Sales Forecast by Country (2025-2030) & (K Units)
Table 115. Europe Amifostine Sales Market Share Forecast by Country (2025-2030)
Table 116. Europe Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 117. Europe Amifostine Market Size by Country (2019-2024) & (US$ Million)
Table 118. Europe Amifostine Market Share by Country (2019-2024)
Table 119. Europe Amifostine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 120. Europe Amifostine Market Share Forecast by Country (2025-2030)
Table 121. Asia-Pacific Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 122. Asia-Pacific Amifostine Sales by Country (2019-2024) & (K Units)
Table 123. Asia-Pacific Amifostine Sales Market Share by Country (2019-2024)
Table 124. Asia-Pacific Amifostine Sales Forecast by Country (2025-2030) & (K Units)
Table 125. Asia-Pacific Amifostine Sales Market Share Forecast by Country (2025-2030)
Table 126. Asia-Pacific Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 127. Asia-Pacific Amifostine Market Size by Country (2019-2024) & (US$ Million)
Table 128. Asia-Pacific Amifostine Market Share by Country (2019-2024)
Table 129. Asia-Pacific Amifostine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 130. Asia-Pacific Amifostine Market Share Forecast by Country (2025-2030)
Table 131. Latin America Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 132. Latin America Amifostine Sales by Country (2019-2024) & (K Units)
Table 133. Latin America Amifostine Sales Market Share by Country (2019-2024)
Table 134. Latin America Amifostine Sales Forecast by Country (2025-2030) & (K Units)
Table 135. Latin America Amifostine Sales Market Share Forecast by Country (2025-2030)
Table 136. Latin America Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 137. Latin America Amifostine Market Size by Country (2019-2024) & (US$ Million)
Table 138. Latin America Amifostine Market Share by Country (2019-2024)
Table 139. Latin America Amifostine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 140. Latin America Amifostine Market Share Forecast by Country (2025-2030)
Table 141. Middle East and Africa Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 142. Middle East and Africa Amifostine Sales by Country (2019-2024) & (K Units)
Table 143. Middle East and Africa Amifostine Sales Market Share by Country (2019-2024)
Table 144. Middle East and Africa Amifostine Sales Forecast by Country (2025-2030) & (K Units)
Table 145. Middle East and Africa Amifostine Sales Market Share Forecast by Country (2025-2030)
Table 146. Middle East and Africa Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 147. Middle East and Africa Amifostine Market Size by Country (2019-2024) & (US$ Million)
Table 148. Middle East and Africa Amifostine Market Share by Country (2019-2024)
Table 149. Middle East and Africa Amifostine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 150. Middle East and Africa Amifostine Market Share Forecast by Country (2025-2030)
Table 151. Key Raw Materials
Table 152. Raw Materials Key Suppliers
Table 153. Amifostine Distributors List
Table 154. Amifostine Customers List
Table 155. Research Programs/Design for This Report
Table 156. Authors List of This Report
Table 157. Secondary Sources
Table 158. Primary Sources
LIST OF FIGURES
Figure 1. Amifostine Product Picture
Figure 2. Global Amifostine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Amifostine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Amifostine Sales (2019-2030) & (K Units)
Figure 5. Product Picture of 400mg/Dose
Figure 6. Global 400mg/Dose Sales YoY Growth (2019-2030) & (K Units)
Figure 7. Product Picture of 500mg/Dose
Figure 8. Global 500mg/Dose Sales YoY Growth (2019-2030) & (K Units)
Figure 9. Global Amifostine Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global Amifostine Market Share by Type 2023 VS 2030
Figure 11. North America Amifostine Sales Market Share in Volume by Type in 2023
Figure 12. North America Amifostine Sales Market Share in Value by Type in 2023
Figure 13. Europe Amifostine Sales Market Share in Volume by Type in 2023
Figure 14. Europe Amifostine Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific Amifostine Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific Amifostine Sales Market Share in Value by Type in 2023
Figure 17. Latin America Amifostine Sales Market Share in Volume by Type in 2023
Figure 18. Latin America Amifostine Sales Market Share in Value by Type in 2023
Figure 19. Middle East and Africa Amifostine Sales Market Share in Volume by Type in 2023
Figure 20. Middle East and Africa Amifostine Sales Market Share in Value by Type in 2023
Figure 21. Global Top 5 and 10 Amifostine Players Market Share by Revenue in 2023
Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Product Picture of Head and Neck Cancer Adjuvant Therapy
Figure 24. Global Head and Neck Cancer Adjuvant Therapy Sales YoY Growth (2019-2030) & (K Units)
Figure 25. Product Picture of Others
Figure 26. Global Others Sales YoY Growth (2019-2030) & (K Units)
Figure 27. Global Amifostine Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 28. Global Amifostine Market Share by Application 2023 VS 2030
Figure 29. North America Amifostine Sales Market Share in Volume by Application in 2023
Figure 30. North America Amifostine Sales Market Share in Value by Application in 2023
Figure 31. Europe Amifostine Sales Market Share in Volume by Application in 2023
Figure 32. Europe Amifostine Sales Market Share in Value by Application in 2023
Figure 33. Asia-Pacific Amifostine Sales Market Share in Volume by Application in 2023
Figure 34. Asia-Pacific Amifostine Sales Market Share in Value by Application in 2023
Figure 35. Latin America Amifostine Sales Market Share in Volume by Application in 2023
Figure 36. Latin America Amifostine Sales Market Share in Value by Application in 2023
Figure 37. Middle East and Africa Amifostine Sales Market Share in Volume by Application in 2023
Figure 38. Middle East and Africa Amifostine Sales Market Share in Value by Application in 2023
Figure 39. North America Amifostine Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Figure 40. North America Amifostine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 41. North America Amifostine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Amifostine Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. Europe Amifostine Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Figure 44. Europe Amifostine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 45. Europe Amifostine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 46. Europe Amifostine Market Share by Country: 2019 VS 2023 VS 2030
Figure 47. Asia-Pacific Amifostine Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Figure 48. Asia-Pacific Amifostine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Amifostine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Asia-Pacific Amifostine Market Share by Country: 2019 VS 2023 VS 2030
Figure 51. Latin America Amifostine Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Figure 52. Latin America Amifostine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 53. Latin America Amifostine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Latin America Amifostine Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East and Africa Amifostine Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Figure 56. Middle East and Africa Amifostine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 57. Middle East and Africa Amifostine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 58. Middle East and Africa Amifostine Market Share by Country: 2019 VS 2023 VS 2030
Figure 59. Amifostine Value Chain
Figure 60. Key Raw Materials Price
Figure 61. Manufacturing Cost Structure
Figure 62. Amifostine Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
Figure 1. Amifostine Product Picture
Figure 2. Global Amifostine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Amifostine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Amifostine Sales (2019-2030) & (K Units)
Figure 5. Product Picture of 400mg/Dose
Figure 6. Global 400mg/Dose Sales YoY Growth (2019-2030) & (K Units)
Figure 7. Product Picture of 500mg/Dose
Figure 8. Global 500mg/Dose Sales YoY Growth (2019-2030) & (K Units)
Figure 9. Global Amifostine Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global Amifostine Market Share by Type 2023 VS 2030
Figure 11. North America Amifostine Sales Market Share in Volume by Type in 2023
Figure 12. North America Amifostine Sales Market Share in Value by Type in 2023
Figure 13. Europe Amifostine Sales Market Share in Volume by Type in 2023
Figure 14. Europe Amifostine Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific Amifostine Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific Amifostine Sales Market Share in Value by Type in 2023
Figure 17. Latin America Amifostine Sales Market Share in Volume by Type in 2023
Figure 18. Latin America Amifostine Sales Market Share in Value by Type in 2023
Figure 19. Middle East and Africa Amifostine Sales Market Share in Volume by Type in 2023
Figure 20. Middle East and Africa Amifostine Sales Market Share in Value by Type in 2023
Figure 21. Global Top 5 and 10 Amifostine Players Market Share by Revenue in 2023
Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Product Picture of Head and Neck Cancer Adjuvant Therapy
Figure 24. Global Head and Neck Cancer Adjuvant Therapy Sales YoY Growth (2019-2030) & (K Units)
Figure 25. Product Picture of Others
Figure 26. Global Others Sales YoY Growth (2019-2030) & (K Units)
Figure 27. Global Amifostine Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 28. Global Amifostine Market Share by Application 2023 VS 2030
Figure 29. North America Amifostine Sales Market Share in Volume by Application in 2023
Figure 30. North America Amifostine Sales Market Share in Value by Application in 2023
Figure 31. Europe Amifostine Sales Market Share in Volume by Application in 2023
Figure 32. Europe Amifostine Sales Market Share in Value by Application in 2023
Figure 33. Asia-Pacific Amifostine Sales Market Share in Volume by Application in 2023
Figure 34. Asia-Pacific Amifostine Sales Market Share in Value by Application in 2023
Figure 35. Latin America Amifostine Sales Market Share in Volume by Application in 2023
Figure 36. Latin America Amifostine Sales Market Share in Value by Application in 2023
Figure 37. Middle East and Africa Amifostine Sales Market Share in Volume by Application in 2023
Figure 38. Middle East and Africa Amifostine Sales Market Share in Value by Application in 2023
Figure 39. North America Amifostine Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Figure 40. North America Amifostine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 41. North America Amifostine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Amifostine Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. Europe Amifostine Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Figure 44. Europe Amifostine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 45. Europe Amifostine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 46. Europe Amifostine Market Share by Country: 2019 VS 2023 VS 2030
Figure 47. Asia-Pacific Amifostine Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Figure 48. Asia-Pacific Amifostine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Amifostine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Asia-Pacific Amifostine Market Share by Country: 2019 VS 2023 VS 2030
Figure 51. Latin America Amifostine Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Figure 52. Latin America Amifostine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 53. Latin America Amifostine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Latin America Amifostine Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East and Africa Amifostine Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Figure 56. Middle East and Africa Amifostine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 57. Middle East and Africa Amifostine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 58. Middle East and Africa Amifostine Market Share by Country: 2019 VS 2023 VS 2030
Figure 59. Amifostine Value Chain
Figure 60. Key Raw Materials Price
Figure 61. Manufacturing Cost Structure
Figure 62. Amifostine Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
